Antileishmanial Activity of Natural Product-Like Naphthoquinones

Citation

Malerich, J. P., Li, J., Joder, D., Vieria, É. L. M., Keesen, T. S. L., Vaidyanathan, R., . . . Tanga, M. J. (2013). Antileishmanial activity of natural product-like naphthoquinones. Drug Development Research, 74(4), 237-241. doi: 10.1002/ddr.21067

Abstract

The antileishmanial activity of compounds inspired by naphthoquinone secondary metabolites from Bignoniaceae is presented. Three structural series of compounds from a common biosynthetic pathway were evaluated against Leishmania major. Compound (15), an analog of the natural product pinnatal, was more active than amphotericin B against L. major. When tested against L. (Viannia) braziliensis and L. infantum, compound 15 showed similar activity to amphotericin B.


Read more from SRI

  • Banner and attendees at the IEEE Hard Tech Venture Summit

    Cultivating hard tech startups that scale

    IEEE’s Hard Tech Venture Summit convened innovators at SRI to refine strategies and build new networks.

  • Patient going into a MRI

    Bringing surgical tools inside the MRI

    Drawing on SRI’s unique innovation ecosystem, the startup Medical Devices Corner is seeking to improve cancer surgery by advancing MRI-safe teleoperation.

  • Christopher Mims and Susan Patrick

    PARC Forum: How to AI

    The Wall Street Journal tech columnist Christopher Mims and SRI Education’s Susan Patrick discuss how AI can strengthen human agency.